Research we’re watching: Two osteoporosis drugs better than one
A combination of two osteoporosis drugs-denosumab (Prolia) and teriparatide (Forteo)-increases bone mineral density in women at risk for fractures better than either drug alone.
Content restricted. Requires subscription